Ticker Details
ARS Pharmaceuticals, Inc.
IPO Date:	December 4, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$547.46M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 3.49%
Avg Daily Range (30 D):	$0.29 | 4.82%
Avg Daily Range (90 D):	$0.31 | 4.01%

Institutional Daily Volume
Avg Daily Volume:	1.13M
Avg Daily Volume (30 D):	2.02M
Avg Daily Volume (90 D):	1.73M

Trade Size
Avg Trade Size (Sh.):	91
Avg Trade Size (Sh.) (30 D):	112
Avg Trade Size (Sh.) (90 D):	95

Institutional Trades
Total Institutional Trades:	952
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$1.25M
Avg Institutional Trade (90 D):	$1.52M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.79M
Avg Closing Trade (30 D):	$1.27M
Avg Closing Trade (90 D):	$1.61M
Avg Closing Volume:	169.53K

News

Aug 6, 2026 @ 7:46 PM Gainey McKenna & Egleston Announces A Class Action... Source: Gainey Mckenna & Egleston

Aug 5, 2026 @ 9:43 PM SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies ... Source: Levi & Korsinsky, Llp

May 15, 2026 @ 10:00 AM ARS Pharmaceuticals Reports First Quarter 2026 Fin... Source: Ars Pharmaceuticals, Inc.

May 7, 2026 @ 12:00 PM ARS Pharmaceuticals Announces Conference Call and ... Source: Not Specified

Nov 10, 2025 @ 11:00 AM ARS Pharmaceuticals Reports Third Quarter 2025 Fin... Source: Ars Pharmaceuticals

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.63	$-.61	$-.42
Diluted EPS	$-.63	$-.61	$-.42
Revenue	$33.66M	$22.68M	$28.09M
Gross Profit
Net Income / Loss	$-62.34M	$-60.62M	$-41.32M
Operating Income / Loss	$-61.47M	$-60.15M	$-41.47M
Cost of Revenue
Net Cash Flow	$-16.16M	$-17M	$-18.24M
PE Ratio